Builder Investment Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$521K Hold
1,440
0.1% 74
2026
Q1
$507K Hold
1,440
0.11% 74
2025
Q4
$471K Hold
1,440
0.1% 73
2025
Q3
$406K Hold
1,440
0.09% 75
2025
Q2
$402K Hold
1,440
0.1% 76
2025
Q1
$449K Hold
1,440
0.13% 71
2024
Q4
$375K Hold
1,440
0.1% 76
2024
Q3
$464K Hold
1,440
0.12% 68
2024
Q2
$450K Hold
1,440
0.12% 66
2024
Q1
$409K Hold
1,440
0.12% 71
2023
Q4
$415K Hold
1,440
0.15% 67
2023
Q3
$387K Hold
1,440
0.15% 68
2023
Q2
$320K Hold
1,440
0.12% 73
2023
Q1
$348K Hold
1,440
0.15% 70
2022
Q4
$378K Buy
+1,440
New +$386K 0.18% 62

Other funds holding AMGN

Builder Investment Group's AMGN Position: Q2 2026 in Review

Builder Investment Group held its Amgen (AMGN) position steady in Q2 2026 at 1,440 shares worth $521K. The position accounts for 0.1% of the portfolio, ranked #74.

Builder Investment Group first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. 738 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Builder Investment Group held 1,440 shares of Amgen worth $521K as of Q2 2026.
  • Builder Investment Group left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.1% of Builder Investment Group's portfolio in Q2 2026, its #74 holding.
  • Builder Investment Group first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
  • 738 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Builder Investment Group's 13F filing for Q2 2026, filed 17 Jul 2026.